Enough Of Wasting Away From Cancer: Companies Gear Up To Tackle Cachexia
Delveinsight
AUGUST 2, 2020
Cachexia is observed as a result of underlying diseases, including cancer, AIDS, tuberculosis, chronic heart failure, hormonal deficiency, and others. NGM120 is a first-in-class antagonistic antibody, which binds glial cell-derived neurotrophic factor receptor alpha-like (GFRAL) and inhibits growth differentiation factor 15 (GDF15).
Let's personalize your content